Hemochromatosis
Hemochromatosis is a disorder of excessive body iron accumulation. The common inherited form is usually related to HFE gene variants and can damage the liver, joints, pancreas, heart and endocrine organs if iron overload is not recognized and treated.
At a glance
Quick facts
- Core problem
- Excess iron absorption/storage
- Key blood tests
- Transferrin saturation and ferritin
- Common genetic test
- HFE variants
- First-line treatment
- Therapeutic phlebotomy
- Major organ risk
- Liver
- Family implication
- First-degree relatives may need testing
Names & terminology
How this entity may be named or searched
- Hemochromatosis
- Clinical disorder in which excessive iron accumulates in tissues.
- Hereditary hemochromatosis
- Inherited form, commonly associated with HFE variants in populations of European ancestry.
- Iron overload
- Broader state that can also result from repeated transfusions or other disorders.
- Ferritin
- Iron-storage protein; it can rise from inflammation or liver disease even without hemochromatosis.
Structured entity profile
Clinical profile
Overview
Hemochromatosis causes progressive accumulation of iron because intestinal absorption or iron input exceeds the body’s ability to regulate storage. In common hereditary hemochromatosis, impaired hepcidin signaling leads to excessive iron absorption. Secondary iron overload can occur after repeated transfusions or in other hematologic and liver disorders. [1] [2]
Excess iron promotes oxidative injury and fibrosis in vulnerable organs. The liver is particularly important because progressive injury can lead to cirrhosis and hepatocellular carcinoma risk. Iron can also accumulate in the pancreas, heart, pituitary and joints, contributing to diabetes, cardiomyopathy, rhythm disturbances, hormonal dysfunction and characteristic arthropathy. [1] [2]
An elevated ferritin level alone does not establish hemochromatosis because ferritin is also an acute-phase reactant and rises in metabolic liver disease, alcohol-related liver injury, infection and inflammation. The diagnostic pattern combines transferrin saturation, ferritin, family history, genotype and evidence of organ iron or injury. [1] [2] [3]
Symptoms and warning signs
Early hereditary hemochromatosis is often asymptomatic. When symptoms occur, they may include fatigue, weakness, pain in the knuckle joints, abdominal discomfort, reduced libido or skin darkening. Later disease can present through diabetes, liver abnormalities, heart failure, arrhythmia or endocrine dysfunction rather than a distinctive iron-overload symptom. [1] [2]
Hemochromatosis usually evolves gradually, but urgent care is needed for complications such as new chest pain, severe shortness of breath, fainting, gastrointestinal bleeding, confusion with advanced liver disease or severe infection. People with cirrhosis need structured specialist surveillance because treatment of iron overload does not remove all cancer risk. [1] [2]
SYMPTOM MATRIX
Early iron overload can be silent
Symptoms are often nonspecific until organ injury becomes clinically apparent.
- Fatigue or weakness
- Joint pain
- Abdominal discomfort
- Reduced libido
- Abnormal liver tests
- Diabetes
- Arrhythmia or heart failure
- Skin darkening
- Chest pain or syncope
- Confusion with liver disease
- GI bleeding
- Severe infection after raw shellfish exposure
These features require urgent assessment.
Diagnosis
Initial testing typically includes transferrin saturation and serum ferritin. Persistently elevated transferrin saturation raises suspicion of increased iron absorption, while ferritin helps estimate iron stores and monitor treatment. Results are interpreted alongside liver tests, blood count, alcohol use, metabolic factors and inflammatory conditions. [1] [2]
Genetic testing for HFE variants is used when hereditary hemochromatosis is suspected. NIDDK notes that finding two copies of HFE C282Y confirms common primary hemochromatosis in the appropriate clinical context. MRI can estimate liver iron noninvasively. Liver biopsy is now selective, used when diagnosis or fibrosis staging cannot be resolved by less invasive methods. [1] [2] [3]
High ferritin can reflect fatty liver disease, alcohol use, chronic inflammation, infection, malignancy or metabolic syndrome. Iron overload can also result from transfusion dependence, ineffective erythropoiesis and rarer genetic disorders. The distinction matters because standard phlebotomy is appropriate for many hereditary cases but may be unsafe or impractical in people who are anemic. [2] [3]
Diagnostic pathway
Interpret ferritin together with transferrin saturation
Genetics and organ assessment determine whether high iron markers represent hereditary disease and clinically important overload.
A high ferritin value by itself is not synonymous with hemochromatosis.
Causes, risk factors and clinical context
Hereditary risk is concentrated in families carrying pathogenic variants, but penetrance varies: not everyone with a high-risk genotype develops clinically important iron overload. Men often manifest earlier than premenopausal women because menstruation and pregnancy reduce iron stores. Alcohol and chronic liver disease can amplify liver injury. [1] [2]
Iron accumulation occurs over years. Identifying disease before cirrhosis, diabetes or cardiac damage provides the best opportunity to prevent complications. Iron stores can usually be lowered substantially with treatment, after which maintenance therapy prevents reaccumulation. Established joint symptoms may improve less than fatigue or biochemical abnormalities. [1] [2] [3]
Complications and why the diagnosis matters
Major complications include cirrhosis, liver cancer, diabetes, cardiomyopathy, arrhythmia, hypogonadism and arthropathy. Iron-overloaded patients are also particularly susceptible to severe infection from certain organisms found in raw shellfish or seawater, including Vibrio vulnificus, which supports specific food-safety counseling. [1] [2]
People treated before irreversible organ damage often have an excellent long-term outlook. Cirrhosis changes prognosis because liver-related complications and hepatocellular carcinoma risk can persist even after iron stores normalize. Prognosis therefore depends on both iron burden and the stage of organ injury at diagnosis. [1] [2] [3]
Treatment and management
Therapeutic phlebotomy is the standard treatment for most people with hereditary hemochromatosis who can tolerate blood removal. Treatment initially removes blood frequently while ferritin falls, then transitions to individualized maintenance. The exact schedule depends on hemoglobin, ferritin, symptoms and comorbidities and should be supervised clinically. [1] [2]
Management includes treating diabetes, heart disease, liver disease or endocrine complications and reducing additional liver injury. Routine severe dietary iron restriction is usually unnecessary, but iron supplements should generally be avoided unless prescribed. Vitamin C supplements can increase iron absorption and are discussed with the care team. [1] [2] [3]
Chelation is not a routine substitute for phlebotomy in uncomplicated hereditary hemochromatosis; it is used in selected iron-overload states when phlebotomy is unsuitable. People should not donate or remove blood at an unsupervised frequency based solely on a ferritin result because anemia and other diagnoses must be excluded. [1] [2]
Treatment & care hub
Remove excess iron before irreversible organ damage develops
Phlebotomy is simple and effective for most hereditary hemochromatosis.
Remove blood on a monitored schedule
Frequency is adjusted to hemoglobin and ferritin response.
Prevent iron reaccumulation
Periodic phlebotomy continues after depletion when needed.
Manage liver, cardiac and endocrine disease
Iron reduction does not automatically reverse established organ damage.
Offer appropriate testing to relatives
First-degree relatives can benefit from early detection.
Chelation is reserved for selected patients in whom phlebotomy is unsuitable or for other forms of iron overload.
Follow-up, recovery and prevention
Ferritin and blood counts are monitored during depletion and maintenance therapy. Liver fibrosis assessment and liver-cancer surveillance are appropriate when advanced fibrosis or cirrhosis is present. First-degree relatives should discuss iron and genetic testing with a clinician because early recognition can prevent organ injury. [1] [2]
Inherited hemochromatosis cannot be prevented genetically, but complications can often be prevented by early detection and iron removal. Avoiding excess alcohol is especially important when liver iron is high. People with iron overload should avoid raw shellfish because of the risk of severe Vibrio infection and should not take iron supplements without medical indication. [1] [2] [3]
Special situations and care pathway
Secondary iron overload after chronic transfusion often requires chelation rather than phlebotomy because patients may already be anemic. Pregnancy generally pauses therapeutic phlebotomy unless there is a compelling specialist reason. Genetic counseling can help families understand the difference between carrying HFE variants and having clinically significant iron overload. [1] [2] [3]
Confirm a reproducible iron-overload pattern, identify hereditary versus secondary causes, assess liver and other organ involvement, start iron-reduction therapy appropriate to the mechanism, and monitor ferritin and complications over time. Family testing should be integrated when hereditary disease is established. [1] [2]
When to seek urgent medical care
Seek urgent care for chest pain, fainting, severe shortness of breath, gastrointestinal bleeding, confusion, severe abdominal swelling or rapidly progressive illness. These features suggest organ complications rather than uncomplicated iron overload. [1] [2]
Clinical context
Genotype does not equal clinical disease
Hereditary susceptibility is common in some populations, but clinically important iron overload depends on penetrance and additional factors.
Common questions
Frequently asked questions
No. Ferritin can rise from inflammation, liver disease, alcohol use and metabolic conditions, so transferrin saturation and the wider clinical context are needed.
Regular therapeutic phlebotomy is first-line for most people who can safely undergo blood removal.
Lowering iron can prevent further injury, but established advanced scarring may not fully reverse and liver-cancer surveillance can remain necessary.
First-degree relatives of a person with hereditary hemochromatosis should discuss appropriate iron and genetic testing with a clinician.
Usually not. Treatment focuses on iron removal; avoiding iron supplements, excess alcohol and raw shellfish is more important than extreme dietary restriction.
Sources
- NIDDK — Hemochromatosis
- NIDDK — Diagnosis of Hemochromatosis
- NIDDK — Treatment of Hemochromatosis
This article is based on trusted medical sources and is awaiting clinician review. It is not a substitute for personalized medical advice.